Treace Medical Concepts Stock Performance
| TMCI Stock | USD 8.75 0.06 0.69% |
On a scale of 0 to 100, Treace Medical holds a performance score of 8. The entity has a beta of 1.5, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Treace Medical will likely underperform. Please check Treace Medical's semi variance, day typical price, and the relationship between the maximum drawdown and accumulation distribution , to make a quick decision on whether Treace Medical's existing price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Treace Medical Concepts are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Treace Medical demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 5.33 | Five Day Return 7.68 | Year To Date Return 10.42 | Ten Year Return (65.96) | All Time Return (65.96) |
1 | Disposition of 11905 shares by John Treace of Treace Medical subject to Rule 16b-3 | 01/10/2025 |
2 | Acquisition by Hair Mark of 187500 shares of Treace Medical subject to Rule 16b-3 | 01/22/2025 |
3 | What To Expect From Treace Medical Concepts Inc Q4 2024 Earnings | 02/26/2025 |
4 | Treace Medical Concepts Inc Reports Q4 2024 EPS of 0. ... | 02/27/2025 |
5 | Treace Medical Concepts Inc Q4 2024 Earnings Call Highlights Strong Revenue Growth and ... | 02/28/2025 |
6 | Acquisition by John Treace of 60000 shares of Treace Medical at 8.7344 subject to Rule 16b-3 | 03/04/2025 |
7 | Disposition of 3684 shares by Hair Mark of Treace Medical subject to Rule 16b-3 | 03/10/2025 |
8 | Disposition of 50000 shares by Sean Scanlan of Treace Medical at 1.05 subject to Rule 16b-3 | 03/17/2025 |
9 | William Blair Investment Management LLC Purchases 546,787 Shares of Treace Medical Concepts, Inc. - MarketBeat | 03/20/2025 |
| Begin Period Cash Flow | 13 M |
Treace |
Treace Medical Relative Risk vs. Return Landscape
If you would invest 708.00 in Treace Medical Concepts on December 25, 2024 and sell it today you would earn a total of 161.00 from holding Treace Medical Concepts or generate 22.74% return on investment over 90 days. Treace Medical Concepts is currently generating 0.4235% in daily expected returns and assumes 3.9908% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Treace, and 92% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Treace Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Treace Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Treace Medical Concepts, and traders can use it to determine the average amount a Treace Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1061
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TMCI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.99 actual daily | 35 65% of assets are more volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.11 actual daily | 8 92% of assets perform better |
Based on monthly moving average Treace Medical is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Treace Medical by adding it to a well-diversified portfolio.
Treace Medical Fundamentals Growth
Treace Stock prices reflect investors' perceptions of the future prospects and financial health of Treace Medical, and Treace Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Treace Stock performance.
| Return On Equity | -0.44 | ||||
| Return On Asset | -0.15 | ||||
| Profit Margin | (0.27) % | ||||
| Operating Margin | (0) % | ||||
| Current Valuation | 538.13 M | ||||
| Shares Outstanding | 62.62 M | ||||
| Price To Book | 4.82 X | ||||
| Price To Sales | 2.60 X | ||||
| Revenue | 209.36 M | ||||
| Gross Profit | 168.26 M | ||||
| EBITDA | (42.07 M) | ||||
| Net Income | (55.74 M) | ||||
| Cash And Equivalents | 101.53 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 69.65 M | ||||
| Debt To Equity | 0.99 % | ||||
| Current Ratio | 8.13 X | ||||
| Book Value Per Share | 1.81 X | ||||
| Cash Flow From Operations | (37.17 M) | ||||
| Earnings Per Share | (0.90) X | ||||
| Market Capitalization | 544.16 M | ||||
| Total Asset | 217.09 M | ||||
| Retained Earnings | (189.99 M) | ||||
| Working Capital | 126.48 M | ||||
About Treace Medical Performance
By evaluating Treace Medical's fundamental ratios, stakeholders can gain valuable insights into Treace Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Treace Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Treace Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 348.67 | 215.95 | |
| Return On Tangible Assets | (0.28) | (0.30) | |
| Return On Capital Employed | (0.31) | (0.32) | |
| Return On Assets | (0.26) | (0.27) | |
| Return On Equity | (0.49) | (0.52) |
Things to note about Treace Medical Concepts performance evaluation
Checking the ongoing alerts about Treace Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Treace Medical Concepts help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Treace Medical had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 209.36 M. Net Loss for the year was (55.74 M) with profit before overhead, payroll, taxes, and interest of 168.26 M. | |
| Treace Medical Concepts currently holds about 101.53 M in cash with (37.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| Treace Medical has a poor financial position based on the latest SEC disclosures | |
| Roughly 61.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: William Blair Investment Management LLC Purchases 546,787 Shares of Treace Medical Concepts, Inc. - MarketBeat |
- Analyzing Treace Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Treace Medical's stock is overvalued or undervalued compared to its peers.
- Examining Treace Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Treace Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Treace Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Treace Medical's stock. These opinions can provide insight into Treace Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Treace Stock analysis
When running Treace Medical's price analysis, check to measure Treace Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Treace Medical is operating at the current time. Most of Treace Medical's value examination focuses on studying past and present price action to predict the probability of Treace Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Treace Medical's price. Additionally, you may evaluate how the addition of Treace Medical to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |